Avenue Therapeutics

Fortress Biotech appoints Lucy Lu, MD, president and chief executive officer of Avenue Therapeutics

Wednesday, July 5, 2017

Fortress Biotech, Inc., a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announced that Lucy Lu, MD, has been named President and Chief Executive Officer of its Fortress subsidiary Avenue Therapeutics, Inc. Dr. Lu has served as interim Chief Executive Officer of Avenue since inception. Fortress also announced that Ms. Robyn Hunter has been appointed Chief Financial Officer of Fortress, a role formerly held by Dr. Lu.

[Read More]